Literature DB >> 30706100

[Hepatocellular carcinomas and their mimics].

H-P Fischer1, D Goltz2.   

Abstract

High resolution cross-sectional imaging techniques means that even small, well-differentiated hepatocellular tumors can also be diagnosed with biopsy. In cirrhotic liver tissue, macroregenerative and dysplastic nodules must be discriminated from hepatocellular cancer (HCC). In non-cirrhotic liver tissue the differential diagnosis includes hepatocellular adenoma, macroregeneratory nodules, fibrolamellar carcinoma, as well as primary tumors and metastases. The diagnostic procedure includes matrix diagnosis of the tumor-bearing liver tissue, cyto- and histomorphologic analysis including capillarization of vascular bed, and adapted immunohistological testing with antibodies which underline possible malignancy or hepatocellular differentiation. A flow chart for the diagnosis of hepatocellular carcinomas and their mimics on liver biopsies is presented.

Entities:  

Keywords:  Biopsy; Differential diagnosis; Immunohistochemistry; Liver neoplasms; Molecular pathology

Mesh:

Year:  2019        PMID: 30706100     DOI: 10.1007/s00292-018-0565-0

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  29 in total

1.  Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.

Authors:  Jun-Yi Lei; Patricia A Bourne; P Anthony diSant'Agnese; Jiaoti Huang
Journal:  Am J Clin Pathol       Date:  2006-04       Impact factor: 2.493

2.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

Review 3.  Hepatoid adenocarcinoma - review of the literature illustrated by a rare case originating in the peritoneal cavity.

Authors:  Georgia Metzgeroth; Philipp Ströbel; Tobias Baumbusch; Andreas Reiter; Jan Hastka
Journal:  Onkologie       Date:  2010-04-13

4.  Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.

Authors:  Marcela Salomao; Woojin M Yu; Robert S Brown; Jean C Emond; Jay H Lefkowitch
Journal:  Am J Surg Pathol       Date:  2010-11       Impact factor: 6.394

5.  Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia.

Authors: 
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

6.  Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.

Authors:  C Röcken; J Licht; A Roessner; S Carl-McGrath
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

7.  Malignant mediastinal germ cell tumor with pure hepatoid differentiation.

Authors:  Ingo Theuerkauf; Cristoph Axmann; Martin Wolff; Klaus Tschubel; Hans-Peter Fischer
Journal:  Pathol Res Pract       Date:  2002       Impact factor: 3.250

8.  [Primary neuroendocrine carcinoma of the liver. From carcinoid tumor to small-cell hepatic carcinoma: case reports and review of the literature].

Authors:  Z Balta; T Sauerbruch; A Hirner; R Büttner; H-P Fischer
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

9.  Primary intrahepatic malignant mesothelioma of epithelioid type.

Authors:  Ines Gütgemann; Jens Standop; Hans-Peter Fischer
Journal:  Virchows Arch       Date:  2006-03-16       Impact factor: 4.064

10.  Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma.

Authors:  Hala M Abdul-Al; Hala R Makhlouf; Guanghua Wang; Zachary D Goodman
Journal:  Hum Pathol       Date:  2007-10-18       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.